Doxycycline and Monocaprin In Situ Hydrogel: Effect on Stability, Mucoadhesion and Texture Analysis and In Vitro

Venu Gopal Reddy Patlolla1,2, William Peter Holbrook2, Sveinbjorn Gizurarson1

  • 1Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland.

Gels (Basel, Switzerland)
|December 15, 2019
PubMed

Insights

This study developed a stable doxycycline and monocaprin hydrogel for oral conditions. The formulation showed stability for one year, with monocaprin enhancing drug release and stability.

Area of Science:

  • Pharmaceutical Sciences
  • Biomaterials Science

Background:

  • Oral diseases are linked to increased Matrix metalloproteinases (MMPs) and microbial activity.
  • Doxycycline and monocaprin show potential for treating oral mucosal conditions.

Purpose of the Study:

  • To develop a stable aqueous hydrogel formulation combining doxycycline and monocaprin.
  • To evaluate the stability, drug-drug interactions, and release kinetics of the combined formulation.

Main Methods:

  • Hydrogels with varying doxycycline and monocaprin concentrations were prepared.
  • Stability was assessed at 4°C for up to 1 year.
  • Drug-drug interactions were analyzed using Fourier-transform infrared spectroscopy (FTIR).

Main Results:

  • Monocaprin addition impacted doxycycline stability negatively but was concentration-dependent.
  • Monocaprin itself remained stable for 1 year.
  • Drug release followed zero-order kinetics via anomalous diffusion, with increased release time.
  • Doxycycline did not inhibit monocaprin's anti-Candidal activity.

Conclusions:

  • A stable doxycycline and monocaprin hydrogel formulation can be achieved for up to 1 year at 4°C.
  • Monocaprin influences hydrogel properties and drug release kinetics.
  • The combination holds promise for managing oral mucosal conditions.